Why daratumumab is effective in multiple myeloma - results from the CASTOR trial
Precision medicine and mutation detection advances in CLL
Is venetoclax appropriate for relapsed CLL patients?
Next steps for advancing the molecular stratification of CLL
What’s new in minimal residual disease (MRD) detection in myeloma?